Fig 1: Effects of stimulation with the KLB agonist, FGF21, on differentiation of human MPCs A, representative immunofluorescence images of MPCs differentiated for 3 days in the presence of different concentrations of FGF21, as indicated. MYHC staining is shown in green. Scale bars = 100 μm. B to E, fusion indices (B), relative levels of MYH3 and MYOG transcripts (C), representative p‐mTOR, mTOR, p‐S6K1 and S6K1 immunoblots together with calculated p‐mTOR/mTOR and p‐S6K1/S6K1 ratios (D), and relative levels of KLB transcript (E) in MPCs differentiated for 3 days in the presence of different concentrations of FGF21. Mean ± SD values are shown together with individual data points. [Colour figure can be viewed at wileyonlinelibrary.com]
Fig 2: Effects of stimulation with the KLB agonist, FGF21, on differentiation of porcine MPCs A, FGF21 and FGF19 levels in the plasma of fetal IUGR and NW littermates, and in healthy newborn piglets (NB). B, representative immunofluorescence images of MPCs differentiated for 3 days in the presence of different concentrations of FGF21, as indicated. MYHC staining is shown in green. Scale bars = 100 µm. C to F, fusion indices (C), relative levels of MYH3 and MYOG transcripts (D), representative p-mTOR, mTOR, p-S6K1 and S6K1 immunoblots together with calculated p-mTOR/mTOR and p-S6K1/S6K1 ratios (E), and relative levels of KLB transcript (F) in MPCs differentiated for 3 days in the presence of different concentrations of FGF21. Mean ± SD values are shown together with individual data points. [Colour figure can be viewed at wileyonlinelibrary.com]
Supplier Page from Wuhan Fine Biotech Co., Ltd. for Porcine FGF21(Fibroblast Growth Factor 21) ELISA Kit